SCHEMBL30403655

SCHEMBL30403655

N#Cc1c(OCc2ccccc2)cc(Cl)nc1Cl

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SQOR Q9Y6N5 1/20 0.49
▸ EGFR P00533 1/20 0.46
▸ ERBB2 P04626 1/20 0.46
▸ MRGPRX4 Q96LA9 2/20 0.44
▸ GRM5 P41594 1/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ MAOB P27338 2/20 0.43
▸ CNR1 P21554 1/20 0.42
▸ HTT P42858 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ PPARG P37231 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ NCOA2 Q15596 1/20 0.41
▸ NCOA1 Q15788 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26608357 0.86 HTT (0.48) SQOREGFRERBB2MRGPRX4GRM5
SCHEMBL26633118 0.80 SQOR (0.53) SQORCNR1L3MBTL1XDH
SCHEMBL31328995 0.79 NPC1 (0.49) SQOREGFRERBB2MRGPRX4NPC1
SCHEMBL17494990 0.75 RHEB (0.46) MRGPRX4NPC1RAB9AHTTSTAT3
SCHEMBL30572982 0.75 XDH (0.41) SQOREGFRERBB2GRM5RAB9A
SCHEMBL26607255 0.75 MAOB (0.48) MRGPRX4GRM5MAOB
SCHEMBL26606918 0.75 XDH (0.41) SQOREGFRERBB2GRM5RAB9A
SCHEMBL26607247 0.75 DCPS (0.45) GRM5MAOBCNR1HTTSTAT3
SCHEMBL26615780 0.75 MAOB (0.44) SQOREGFRERBB2GRM5NPC1
SCHEMBL17495074 0.74 RAB9A (0.52) EGFRNPC1RAB9AMAOBHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116171276-A 3- ((1H-pyrazol-4-yl) methyl) -6'- (phenyl) -2H- [1,2' -bipyridin ] -2-one derivatives and related compounds as GRP139 antagonists in methods of treating E.G. depression 武田药品工业株式会社 2023-05-26 — — CN disclosed
Send feedback